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ABCC6 is a member of the adenosine triphosphate-binding cassette (ABC) gene subfamily C that encodes a protein
(MRP6) involved in active transport of intracellular compounds to the extracellular environment. Mutations in ABCC6
cause pseudoxanthoma elasticum (PXE), an autosomal recessive disorder of the connective tissue characterized by progressive
calciﬁcation of elastic structures in the skin, the eyes, and the cardiovascular system. MRP6 is codiﬁed by 31 exons and contains
1503 amino acids. In addition to a full-length transcript of ABCC6, we have identiﬁed an alternatively spliced variant of ABCC6
from a cDNA of human liver that lacks exons 19 and 24. The novel isoform was named ABCC6 Δ19Δ24. PCR analysis from
cDNA of cell cultures of primary human hepatocites and embryonic kidney conﬁrms the presence of the ABCC6Δ19Δ24 isoform.
Western blot analysis of the embryonic kidney cells shows a band corresponding to the molecular weight of the truncated protein.
Copyright © 2008 Maria Francesca Armentano et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
ABCC6 belongs to the subfamily C of ATP-binding cas-
sette (ABC) transmembrane transporters. The ABCC6 gene
consists of 31 exons encoding for a protein of 1503 amino
acids and has 17 transmembrane spanning domains and
two conserved intracellular nucleotide binding domains
(NBDs).ABCC6ishomologous(45%identityonaminoacid
level) to ABCC1, known to confer multidrug resistance to
tumor cells [1]; for that reason, ABCC6 was classiﬁed as
a multidrug resistance associated protein and also named
MRP6. The NBDs contain two highly conserved Walker
motifs critical for ATP binding and transmembrane trans-
porter functions [2]. Mutations of the ABCC6 gene cause
the pseudoxanthoma elasticum (PXE) (OMIM 177850 and
264800), a multisystem disorder characterized by progressive
calciﬁcation and degeneration of elastic ﬁbers [3].
ABCC6 is highly expressed in human liver and to lesser
extent in the proximal tubules of the kidney and only at
very low levels, if at all, in tissues, such as skin, eyes, and
cardiovascularsystemaﬀectedinpseudoxanthomaelasticum
(PXE) [4, 5]. To date, genetic studies have identiﬁed 165
mutations, mainly missense and nonsense mutations, as well
aslargedeletions(forareviewsee[6]).SinceMRP6ismainly
expressed in liver and kidney, but only low levels are found
in tissues aﬀected by PXE, it has been suggested that PXE is
primarily a metabolic disorder with secondary involvement
of elastic ﬁbers [7]. Despite the high correlation between
ABCC6mutationsandPXE,theactivityofMRP6anditsrole
in PXE remain largely unknown.
Recently, a splice variant leading to a 5bp deletion
in the ABCC6 transcript has been associated with cardiac
dystrophic calciﬁcations in mice [8].
In our study, we report the identiﬁcation of a new variant
of ABCC6 from human liver cDNA lacking exons 19 and 24.
This splice variant was also conﬁrmed in hepatic and renal
cell cultures.
2.MaterialsandMethods
Human liver and kidney BD Marathon-Ready cDNA were
purchased from Clontech. Primary human hepatocites2 Research Letters in Biochemistry
(Cambrex) were maintained in culture medium (Cambrex)
followingthemanufacture’sinstructions.Humanembryonic
kidney cells (Sigma) were maintained in high glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing
10% (v/v) fetal bovine serum, 2mM L-glutamine, 100U
penicillin, and 100μg/mL streptomycin at 37
◦Ci n5 %C O 2.
2.1. Cloningof cDNA EncodingHumanABCC6
To clone ABCC6 cDNA, the forward primer 5 -CACCAT-
GGCCGCGCCTGCTG-3  and the reverse primer 5 -TCA-
GACCAGGCCTGACTCCTG-3  were designed to cloning
the blunt-end PCR product into pcDNA 3.1D/V5-His-
TOPO expression vector (Invitrogen). PCR was performed
using human liver cDNA and Platinum PCR SuperMix
(Invitrogen). The PCR was carried out on a PTC-100 Peltier
Thermal Cycler (MJ Research) and it consisted of 1cycle of
95
◦Cfor2minutes,30cyclesof94
◦C for 45seconds, 62
◦C
for 1minute, 68
◦C for 5minutes and 30seconds, and 68
◦C
for 10minutes. PCR product was isolated from agarose gel,
puriﬁed with the MinElute Gel Extraction kit (Qiagen) and
ligated into pcDNA.3.1D/V5-His-TOPO expression vector.
The recombinant vector was transformed into TOP10 E.
coli cells. Individual clones were cultured overnight in Luria
Bertani broth with 100μg/mL ampicillin, and plasmid was
isolated using the QIAprep Spin Miniprep kit (Qiagen).
2.2. RT-PCRAnalysis
Total RNA was extracted from cultured cells using GenElute
Mammalian Total RNA Miniprep Kit (Sigma). Before reverse
transcription, the concentrations of total RNA were mea-
sured with the GeneQuant pro (Amersham International,
Little Chalfont, UK) and RNA integrity was analyzed under
UV light by visualization of 28S- and 18S-rRNA bands
on a 1.5% agarose gel containing ethidium bromide. Total
intact RNA (1μg) was reverse transcribed using GeneAmp
RNA PCR Core Kit from Applied Biosystems with speciﬁc
primersfortheABCC6geneandMuLVreversetranscriptase,
according to the manufacturers’ instructions. Transcription
reactions without the reverse transcriptase enzyme were per-
formed for negative controls in subsequent PCR reactions.
To amplify region from exon 18 to exon 25 we used
the following primers: 5 -GGCATGAATCTCTCCGGAG-3 
(forward primer in exon 18) and 5 -CTGGAGGGCAGC-
AGAGAC-3  (reverse primer in exon 25). The PCR was
performed on human liver and kidney cDNA and cDNA of
cell cultures. PCR consisted of 1cycle of 95
◦Cf o r2m i n u t e s ;
30cycles of 94
◦C for 45seconds, 58
◦Cf o r1 m i n u t e ,7 2
◦C
for 2.5minutes, and 72
◦C for 10minutes. An aliquot of each
amplicon was analyzed by ethidium bromide visualization
on a 1.5% agarose gel to assess the size of the fragment,
puriﬁed from the gel and directly sequenced.
2.3. Sequencing





Figure 1: (Top) Expression pattern of exon18–exon25 region
of ABCC6 from commercially available human liver and kidney
cDNA (lanes 1 and 2), RNA reverse transcribed of primary
human hepatocites (lane 3), and human embryonic kidney (lane
4). (Bottom) RT-PCR with β-actin primers as a control. The
obtained PCR products were visualized by EtBr-stained agarose gel
electrophoresis.
Kit (Applied Biosystems). The samples were analyzed with
3100AvantGeneticAnalyzer(AppliedBiosystems)according
to the manufacture’s recommendation. The cDNA sequence
of ABCC6 and its splicing variant ABCC6 Δ19Δ24 have
been deposited to GenBank under IDs AM774324 and
AM711638, respectively. The sequences of PCR products
obtained by the ampliﬁcation of exon18–exon25 region from
cell cultures and from human liver and kidney cDNA have
been performed by MWG Biotech.
2.4. Western Blotting
For immunoblot analysis of MRP6 expression, the whole
cell lysate was isolated. HEK293 supplemented with protease
inhibitors (0.1mM PMSF, 5μg/mL aprotinin, 5μg/mL leu-
peptin, and1μg/mL pepstatin) werecentrifuged at1200rpm
for 5minutes. The pellet was resuspended in 1mL of ice cold
RIPA buﬀer (PBS, Igepal CA-630 1%, sodium deoxycholate
0,5%, SDS 0.1%) and incubated on ice for 30minutes; fur-
ther disruption was obtained by sonication. After sonication,
the lysate was incubated on ice for 30minutes and then
centrifuged at 10000xg for 10minutes at 4◦C. The proteins
were precipitated with ﬁve-volume of acetone at −20
◦Co/n,
resuspended in Laemmli buﬀer and separated by SDS-PAGE
(7%). Afterwards, the electrotransfer to an Immobilon-P
transfer membrane (Millipore, Bedford, Mass., US) was
conﬁrmed by the reversible staining with Ponceau Red. After
20minutes in incubation buﬀer (IB) (50mM Tris, 150mM
NaCl, 0,5% Tween-20), membrane was incubated for 1hour
with a polyclonal human antibody, raised against ammi-
noacids 1–70 of human MRP6 (Santa Cruz Biotechnology,
Inc.), diluted 1:400 in IB. After three washings with washing
buﬀer(WB)(50mMTris,150mMNaCl),themembranewas
incubated with an horseradish peroxidase conjugated goat
antirabbitantibody(Sigmaimmunochemical,St.Louis,Mo.,
USA), diluted 1:5000 in IB. Finally, the blot was washed three
times with WB and the proteins were visualized with ECL
(Immun-Star HRP, Biorad, Hercules, Calif., USA).Research Letters in Biochemistry 3
3. Results andDiscussion
ABCC6 was ampliﬁed by PCR from human liver cDNA
using speciﬁc primers and cloned into pCDNA3.1 vector.
Surprisingly, the sequencing of some clones showed two
diﬀerent sequences of 4512 and 4137 nucleotides corre-
sponding to the full length (ABCC6) and a shorter variant of
ABCC6, respectively. A comparison of the shorter one with
the exon/intron boundaries of ABCC6 gene revealed that the
exons 19 and 24 were missing.
In order to verify if the short form, namely, ABCC6
Δ19Δ24, was a result of low-frequency splicing events or
an ABCC6 variant, we ampliﬁed and sequenced the PCR
products of the exon 18–25 region from cDNA of human
liver, human kidney, primary human hepatocites (HI),
and human embryonic kidney cells (HEK293). Liver and
kidney showed essentially the complete exon 18–25 region
(Figure 1 lanes 1 and 2), whereas the variant in which
both exons are missing has been found mainly in HI and
HEK293 (Figure 1 lanes 3 and 4). Then, we suggest that
the isoform lacking exons 19 and 24 may be a product of a
splicing variant diﬀerently distributed in various tissues and
cell lines.
Deletion of the entire exon 19 causes a shift of the
reading frame with insertion of a stop signal at nucleotides
2614–2616 (Figure 2). As consequence of the premature stop
codon, the putative novel protein has a diﬀerent and shorter
C-terminus than that of native MRP6 protein. By a second-
round nested PCR, aberrant splicing of the ABCC6 mRNA
has been previously observed in tissues that do not express
appreciable amount of the protein [5]. More recently, it has
been demonstrated that a missense mutation in ABCC6 gene
ofmicecreatesaprematurestopcodonthat,apartfromPXE,
causes dystrophic cardiac calciﬁcation [8]. These ﬁndings
suggest that truncated forms of ABCC6 can somehow aﬀect
cell activity.
For this reason, the identiﬁcation of diﬀerent splicing
variants of ABCC6 in tissues such as liver and kidney, where
ABCC6 is normally expressed, may be an important step
in understanding the complex function of this gene and
in clarifying the pathogenetic mechanisms of the correlated
diseases.
To examine if the shorter variant encodes an expressed
protein, we analyzed HEK293 by western blot analysis
using an MRP6 N-terminus antibody as described in
the methods (Figure 3). The predicted wild type protein
of nearly 165kDa (MRP6) and a more intense band of
about 100kDa corresponding to the truncated protein
(MRP6 Δ19Δ24) are detected. The additional band between
them could correspond to a diﬀerent glycosylated form of
the truncated protein. Western blot analysis is consistent
with the expression level of the ABCC6Δ19Δ24 variant
showed in Figure 1 and suggests that this isoform prevails
in these cells.
Diﬀerent speculative hypothesis on the function of the
ABCC6Δ19Δ2 4v a r i a n tm a yb ep u tf o r w a r d .
The ﬁnding that ABCC6Δ19Δ24 variant codiﬁes an
expressed protein suggests a variety of functions for the
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Figure 2: Splice event of the ABCC6 Δ19Δ24. (a) ABCC6 wild
transcript; (b) splice event of exons 19 and 24; (c) shift of open
reading frame as a consequence of splicing of exon 19 is indicated






Figure 3: Western blot analysis of MRP6 in HEK293. The
membrane probed with an MRP6 N-term speciﬁc antibody shows
a clear band of about 100kDa, corresponding to the translated
p r o t e i nf r o mt h eA B C C 6Δ19Δ24 isoform (MRP6 Δ19Δ24).
ABCC6 gene and conﬁrms that the alternative splicing is a
diﬀuse mechanism to increase protein diversity in the ABC
transporter superfamily.
We suggest that the translated protein of the ABCC6Δ-
19Δ24 variant is a half transporter. In fact, translation of
the nucleotide sequence of this variant yields a putative
truncated protein of 871 amino acids, encompassing the
ﬁrst two transmembrane domains and the ﬁrst NBD at
the C-terminal end. It is well known that some other
human ABC genes encode half transporters as a consequence
of alternative splicing, such as the ABCA5 gene, which
encodes a protein of 1642 amminoacids and a polypeptide
of 925 amminoacids [9], and the human ABCB6 that
produces two distinct molecular weight forms, localized
in the outer mitochondrial membrane and in the plasma
membrane [10].4 Research Letters in Biochemistry
Abbreviations
ABC: Adenosine triphosphate-binding cassette
PXE: Pseudoxanthoma elasticum
ABCC6 Δ19Δ24: Adenosine triphosphate-binding cassette
subfamily C member 6 lacking exons 19
and 24
NBD: Nucleotide binding domain
MRP: Multidrug resistance associated protein
HI: Primary human hepatocites
HEK293: Human embryonic kidney cells
rRNA: Ribosomal RNA
MuLV: Murine Leukemia Virus
EtBr: Ethidium bromide.
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